MELANIE ANELLO: Open Payments
NPI 1225336696 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 57 payments from 13 companies in 2025. Trend: 2023 $744 · 2024 $1,857 · 2025 $1,516
Food & beverage: $1,502Education: $14
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $402 |
| ABBVIE INC. | 15 | $323 |
| Madrigal Pharmaceuticals | 7 | $227 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Aimmune Therapeutics, Inc. | 4 | $103 |
| Janssen Biotech, Inc. | 4 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $74 |
| QOL Medical, LLC | 2 | $48 |
| Organon LLC | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
Products named: OMVOH, REZDIFFRA, RINVOQ, AIRSUPRA, VOWST, TREMFYA, LINZESS, XIFAXAN.
Industry payments across CA — which companies pay providers there.
